MDCO - The Medicines Company - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

The Medicines Company's activity chart (see below) currently has 88 price targets and 73 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 86.37% with an average time for these price targets to be met of 360.6 days.

Most recent stock forecast was given by from CHARDAN CAPITAL on 26-Nov-2019. First documented stock forecast 06-Jun-2013.

Best performing analysts who are covering MDCO - The Medicines Company:

Yasmeen Rahimi Mayank Mamtani Jay Olson Paul Choi Louise Chen

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 21-Mar-2016

$85

$0.1 (0.12%)

$90

6 years 9 months 25 days ago
(26-Nov-2019)

1/5 (20%)

$1.12 (1.34%)

1338

Buy Since 28-Mar-2019

$85

$0.1 (0.12%)

$100

6 years 9 months 26 days ago
(25-Nov-2019)

1/5 (20%)

$1.25 (1.49%)

243

Buy Since 30-Nov-2017

$68

$-16.9 (-19.91%)

$68

6 years 9 months 26 days ago
(25-Nov-2019)

4/6 (66.67%)

$-15.75 (-18.81%)

235

Hold Since 20-Nov-2019

$59

$-25.9 (-30.51%)

$55

6 years 10 months ago
(20-Nov-2019)

8/9 (88.89%)

$-11.59 (-16.42%)

148

Buy Since 19-Apr-2017

$60

$-24.9 (-29.33%)

$55

6 years 10 months 20 days ago
(31-Oct-2019)

5/5 (100%)

$7.51 (14.31%)

205

Show more analysts

Please expand the browser size to see the chart

What is MDCO (The Medicines Company) average time for price targets to be met?

On average it took 361 days for the stock forecasts to be reached, with an average price target met ratio of 86.37%.

Which analyst most recently updated their price target on MDCO (The Medicines Company)?

Which analyst has the most public recommendations on MDCO (The Medicines Company)?

has 0 price targets and 0 ratings on MDCO

Which analyst is the currently most bullish on MDCO (The Medicines Company)?

Madhu Kumar with the highest potential upside of $0.1

Which analyst is the currently most reserved on MDCO (The Medicines Company)?

David Amsellem with the lowest potential downside of -$53.9

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?